Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Spark-powered bioactivity prediction: a comparison of machine learning approaches

IAES International Journal of Artificial Intelligence · Vol. 15 No. 3 (2026) · hlm. 2423–2430

DOI
10.11591/ijai.v15.i3.pp2423-2430
ISSN
2252-8938, 2089-4872
Terbit
2026-06-01
Penerbit
Institute of Advanced Engineering and Science
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

The arduous and expensive nature of drug discovery has long been a bottleneck in scientific progress. However, recent breakthroughs in computational power, notably machine learning (ML) and artificial intelligence (AI), are profoundly transforming the field. Automated machine learning (AutoML) presents itself as a significant advancement, streamlining model selection, and hyperparameter tuning. This study delves into the potential of AutoML to accelerate drug discovery by comparing it to classical ML techniques. The focus lies on predicting the bioactivity of epidermal growth factor receptor (EGFR), a critical protein implicated in many cancers. By utilizing the scalability of Apache Spark, vast and diverse datasets encompassing biological, chemical, and genomic data tied to EGFR are processed. This comparative analysis aims to evaluate the comparative performance of both approaches, thereby contributing actionable insights to drug discovery research.

Kata kunci

Jaringan kolaborasi para penulis

12 penulis · 18 tautan kepenulisan bersama

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Mohammed V University
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Abdelkerim ZitouniMohammed V University1
Said ChakoukMohammed V University1
Belaïd AhiodMohammed V University1
Bouhouch AdilMohammed V University1
Aicha Er-RafygMohammed V University1
Mossaab Idrissi AlamiMohammed V University1
Fouzia OmaryMohammed V University1
Aicha OussousMohammed V University1
Soumia ZitiMohammed V University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://ijai.iaescore.com/index.php/IJAI/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Spark-powered bioactivity prediction: a comparison of machine learning approaches</dc:title>
	<dc:creator>Tchagafo, Nazif</dc:creator>
	<dc:creator>Ez-Zahout, Abderrahmane</dc:creator>
	<dc:creator>Belaid, Ahiod</dc:creator>
	<dc:subject xml:lang="en-US"></dc:subject>
	<dc:subject xml:lang="en-US">Big data; Epidermal growth factor receptor cancer; Machine learning; Spark machine learning library; Target bioactivity</dc:subject>
	<dc:description xml:lang="en-US">The arduous and expensive nature of drug discovery has long been a bottleneck in scientific progress. However, recent breakthroughs in computational power, notably machine learning (ML) and artificial intelligence (AI), are profoundly transforming the field. Automated machine learning (AutoML) presents itself as a significant advancement, streamlining model selection, and hyperparameter tuning. This study delves into the potential of AutoML to accelerate drug discovery by comparing it to classical ML techniques. The focus lies on predicting the bioactivity of epidermal growth factor receptor (EGFR), a critical protein implicated in many cancers. By utilizing the scalability of Apache Spark, vast and diverse datasets encompassing biological, chemical, and genomic data tied to EGFR are processed. This comparative analysis aims to evaluate the comparative performance of both approaches, thereby contributing actionable insights to drug discovery research.</dc:description>
	<dc:publisher xml:lang="en-US">Institute of Advanced Engineering and Science</dc:publisher>
	<dc:contributor xml:lang="en-US"></dc:contributor>
	<dc:date>2026-06-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ijai.iaescore.com/index.php/IJAI/article/view/27432</dc:identifier>
	<dc:identifier>10.11591/ijai.v15.i3.pp2423-2430</dc:identifier>
	<dc:source xml:lang="en-US">IAES International Journal of Artificial Intelligence (IJ-AI); Vol 15, No 3: June 2026; 2423-2430</dc:source>
	<dc:source>2252-8938</dc:source>
	<dc:source>2089-4872</dc:source>
	<dc:source>10.11591/ijai.v15.i3</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ijai.iaescore.com/index.php/IJAI/article/view/27432/15215</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2026 Nazif Tchagafo, Abderrahmane Ez-Zahout, Belaid Ahiod</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>